Conference Programme

Registration

Welcome Remarks

Harnessing the Body’s Defences

Researchers are discovering that many answers to disease prevention and treatment lie within the immune system itself, rather than solely relying on synthetic drugs. This session will showcase innovative approaches that harness the immune system to develop novel immunotherapies that provide more effective treatments for patients.

• Keynote presentation
• 2 Company Case Studies – Jake Galson, Alchemab, James Price, East Anglian Air Ambulance
• Panel discussion
  – Moderator: Louise Jopling, Babraham Research Campus
  – Panellists: Lennart Spindler, SV Health Investors, Jake Galson, Alchemab, James Price, East Anglian Air Ambulance

Morning Coffee and Networking Break

Adoption of AI in Innovative Drug Discovery

As AI advances in drug discovery, how does our sector strike the right balance between innovation and ensuring it is used responsibly, that will determine what we can adopt to maximise its impact.

• Keynote presentation – Tom Fleming, Arctoris
• 2 Company Case Studies – Catherine Stace, Kuano Limited, Miles Congreve, Isomorphic Labs
• Panel discussion
  – Moderator: Kinga Bercsenyi, Arctoris
  – Panellists: Peter Brady, Orbital Global Group, Rose Hughes, AstraZeneca, Catherine Stace, Kuano Limited

Lunch and Networking

Getting Ready for Clinic

This session will highlight the challenges faced in the pre-clinical research space, and how strategic approaches and early decision making can lead to enhanced clinical readiness, reducing costly setbacks and ultimately accelerating the transition from lab to clinic.

• Keynote presentation – Orestis Tzortzoglou, BioMed Realty
• 2 Company Case Studies – Dave Cook, Quodria, Shefali Bohra, DotPlot
• Panel discussion
  – Moderator: Judit Molnar, Senior Pharmaceutical Physician
  – Panellists: Marin Mladinic, PPD, Dave Cook, Quodria, Christopher Floyd, tranScrip, Debra Babalola, DotPlot

Afternoon Coffee and Networking Break

Invention, Innovation, Industrialisation: How to Accelerate the Journey?

Session Sponsored by:

This session will consider the challenges of translating disruptive innovation to industrial scale adoption. What lessons can be learned from past successes and current trends? There will also be an opportunity to hear insights from an international ecosystem in the way of key learnings from the Boston Bootcamp 2025.

• Panel discussion: Scaling Innovation for Industrial Adoption
  – Moderator: Mike Ward, Clarivate
  – Panellists: Cathy Tralau-Stewart, The Milner Therapeutics Institute and Consortium, Veronica Gray, LifeArc, Jane Dancer, Non-Executive Director, Claire Thompson, Agility Life Sciences
• Keynote presentation – Preeti Bakrania, LifeArc
• Panel discussion: Key Learnings from the Boston Bootcamp 2025
  – Panellists: speaker tbc, Metrion Biosciences, James Dale, PharmEnable Therapeutics, Jon Telfer, RNAvate, Jason Yip, Tailor Bio

Closing Remarks

Tony Jones, One Nucleus

Networking Drinks Reception

End